Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer

Pancreatic cancer is associated with poor prognosis due to limited therapeutic options. Excision repair cross-complementing 3 (ERCC3) is an important member of nucleotide excision repair (NER) that is overexpressed in some cancers and may be regarded as a poor prognostic factor. Yet, its role in pan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shujie, Liu, Wenjing, Ni, Yueli, Wang, Lifeng, Zhu, Yuzhi, Shi, Qiong, Yi, Zihan, Wang, Wenjie, Liu, Lili, Yang, Lijuan, Kuang, Yingmin, Zhu, Yuechun, Zhang, Qiao, Yang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040713/
https://www.ncbi.nlm.nih.gov/pubmed/33854616
http://dx.doi.org/10.7150/jca.54576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040713/
https://www.ncbi.nlm.nih.gov/pubmed/33854616
http://dx.doi.org/10.7150/jca.54576

Ejemplares similares